KR20230000565A - A Feed Stuff Additives for farming fish - Google Patents
A Feed Stuff Additives for farming fish Download PDFInfo
- Publication number
- KR20230000565A KR20230000565A KR1020210082807A KR20210082807A KR20230000565A KR 20230000565 A KR20230000565 A KR 20230000565A KR 1020210082807 A KR1020210082807 A KR 1020210082807A KR 20210082807 A KR20210082807 A KR 20210082807A KR 20230000565 A KR20230000565 A KR 20230000565A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- present
- fish
- group
- Prior art date
Links
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 27
- 239000000654 additive Substances 0.000 title description 3
- 238000009313 farming Methods 0.000 title 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 21
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 17
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 16
- 239000003674 animal food additive Substances 0.000 claims abstract description 14
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 13
- 239000011720 vitamin B Substances 0.000 claims abstract description 13
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 9
- 229960003080 taurine Drugs 0.000 claims abstract description 9
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 claims abstract description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 6
- 229930182817 methionine Natural products 0.000 claims abstract description 6
- 108010024636 Glutathione Proteins 0.000 claims description 8
- 229960003180 glutathione Drugs 0.000 claims description 8
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960000367 inositol Drugs 0.000 claims description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 abstract description 18
- 239000003242 anti bacterial agent Substances 0.000 abstract description 13
- 229940088710 antibiotic agent Drugs 0.000 abstract description 12
- 230000001965 increasing effect Effects 0.000 abstract description 7
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 229940088592 immunologic factor Drugs 0.000 abstract description 2
- 239000000367 immunologic factor Substances 0.000 abstract description 2
- 230000028993 immune response Effects 0.000 abstract 1
- 235000019688 fish Nutrition 0.000 description 24
- 239000000203 mixture Substances 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 230000002708 enhancing effect Effects 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000036039 immunity Effects 0.000 description 7
- 241001529596 Pontinus kuhlii Species 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000269980 Pleuronectidae Species 0.000 description 4
- 235000019730 animal feed additive Nutrition 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229960001661 ursodiol Drugs 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Marine Sciences & Fisheries (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Insects & Arthropods (AREA)
- Physiology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
본 발명의 실시예들은 양식 어류의 사료에 첨가되는 조성물에 관한 것이다.Embodiments of the present invention relate to a composition added to the feed of farmed fish.
축산업 및 어업 등에서는 산업적으로 이용되는 동물들에 대한 질병을 예방하는 문제가 매우 중요하다. 질병을 예방하는데 실패하여 동물들의 질병에 대한 저항성이 낮아지면 생산성이 저감되어 큰 경제적인 손실을 입게 되므로, 질병에 대한 저항성을 높이기 위해 항생제를 사료 등에 처방하고 있다. 그러나 동물의 감염증에 대한 예방 및 치료 대부분이 항생제 사용에 의존하고 있어 항생제 오남용으로 인한 내성균주의 발현으로 기존의 항생제들에 내성을 나타내는 등 문제가 되고 있다. 또한 기존 항생제에 대한 내성 증가로 항생제의 투여량이 증가하여 동물 체내에 항생제가 잔류하는 것 또한 문제가 되고 있다. In the livestock industry and fishery, the problem of preventing diseases of industrially used animals is very important. If the disease resistance of animals is lowered due to failure to prevent disease, productivity is reduced and large economic losses are incurred. Therefore, antibiotics are prescribed for feed and the like to increase disease resistance. However, since most of the prevention and treatment of animal infections depend on the use of antibiotics, there are problems such as resistance to existing antibiotics due to the expression of resistant strains due to misuse and abuse of antibiotics. In addition, due to the increase in resistance to existing antibiotics, the dosage of antibiotics is increased, and the remaining antibiotics in the body of animals is also a problem.
따라서 항생제를 이용하지 않고 동물의 식욕 및 원기를 회복하여 동물들의 활력 및 면역력을 증대시키기 위한 측면에서, 다양한 면역 증강제 및 대사촉진제가 개발되고 있다. 예를 들면, 한국공개특허 제 2007-0031815호에는 흑운모 및 유황을 포함하는 돼지 면역력 증강용 사료첨가제를 개시하고 있다.Therefore, in terms of increasing the vitality and immunity of animals by restoring the appetite and energy of animals without using antibiotics, various immune enhancers and metabolism promoters are being developed. For example, Korean Patent Publication No. 2007-0031815 discloses a feed additive for enhancing pig immunity containing biotite and sulfur.
본 발명의 일 목적은 양식어류의 활력 및 면역을 증진시켜 어류 사육시 각종 항생제의 사용을 저감시킬 수 있는 조성물을 제공하기 위한 것이다. One object of the present invention is to provide a composition capable of reducing the use of various antibiotics in breeding fish by enhancing the vitality and immunity of farmed fish.
이와 같은 본 발명의 해결 과제를 달성하기 위하여, 본 발명의 일 실시예에 따르는 어류용 사료 첨가제는, 글루타치온 34 내지 38 중량부; 베타글루칸 77 내지 84 중량부; B군 비타민 5 내지 6 중량부; 이스트 0.01 내지 1 중량부; 및 타우린, UDCA 및 메티오닌으로 이루어진 군에서 선택되는 적어도 하나를 100 중량부로 포함한다.In order to achieve the above object of the present invention, a feed additive for fish according to an embodiment of the present invention includes 34 to 38 parts by weight of glutathione; 77 to 84 parts by weight of beta glucan; 5 to 6 parts by weight of group B vitamins; 0.01 to 1 part by weight of yeast; and at least one selected from the group consisting of taurine, UDCA and methionine in 100 parts by weight.
본 발명과 관련한 일 예에 따르면, 상기 B군 비타민은 비타민 B1, 비타민 B2, 비타민 B6, 콜린 및 이노시톨을 포함할 수 있다.According to an example related to the present invention, the group B vitamins may include vitamin B 1 , vitamin B 2 , vitamin B 6 , choline and inositol.
또한 상기한 과제를 실현하기 위하여 본 발명의 다른 실시예는, 글루타치온 36.5 중량부, 베타글루칸 80 중량부, 타우린 100 중량부, 비타민 B1 1.5 중량부, 비타민 B2 3.75 중량부, 비타민 B6 0.9 중량부 및 이스트 0.01 내지 1 중량부를 포함하는 어류용 사료 첨가제를 개시한다.In addition, another embodiment of the present invention in order to realize the above object, glutathione 36.5 parts by weight, beta glucan 80 parts by weight, taurine 100 parts by weight, vitamin B 1 1.5 parts by weight, vitamin B 2 3.75 parts by weight, vitamin B 6 0.9 Disclosed is a feed additive for fish comprising 0.01 to 1 part by weight of yeast.
상기와 같이 구성되는 본 발명의 적어도 하나의 실시예에 관련된 어류용 사료 첨가제는 체내에서 대사를 촉진하고 면역반응에 관여하는 면역인자를 증가시켜 동물의 항병력을 높임으로써 동물 사육시 투여 또는 복용시키는 경우에 각종 항생제의 사용을 저감시킬 수 있다.The feed additive for fish related to at least one embodiment of the present invention configured as described above promotes metabolism in the body and increases immune factors involved in immune reactions to increase the anti-pathogenicity of animals, and when administered or taken during breeding of animals. can reduce the use of various antibiotics.
또한, 본 발명에 따른 어류용 사료 첨가제는 간 및 신장에 대한 독성이 저감되어 동물에 장기 투여 또는 복용시킬 수 있는 안전한 사료 첨가제 또는 의약품으로 사용될 수 있다.In addition, the feed additive for fish according to the present invention has reduced liver and kidney toxicity and can be used as a safe feed additive or medicine that can be administered or taken to animals for a long period of time.
본 발명은 글루타치온 35 내지 40 중량부, 베타글루칸 75 내지 85 중량부, B군 비타민 5 내지 6 중량부 및 미량의 이스트를 포함하는 것을 특징으로 한다.The present invention is characterized by comprising 35 to 40 parts by weight of glutathione, 75 to 85 parts by weight of beta glucan, 5 to 6 parts by weight of group B vitamins, and a trace amount of yeast.
이하, 본 발명에 대해 보다 상세히 설명한다Hereinafter, the present invention will be described in more detail.
본 발명에 따르는 어류용 사료 첨가제는 글루타치온, 베타글루칸, B군 비타민 및 이스트(Yeast)를 포함한다.The feed additive for fish according to the present invention includes glutathione, beta glucan, group B vitamins and yeast.
베타 글루칸은 아그로박테리움에 설탕을 탄소원으로 사용하고, 염화암모늄을 질소원으로, 그리고 기타 무기물을 포함하는 발효배지에서 배양하여 생산하였다. 발효가 완료된 후 베타 글루칸은 불용성 상태로 존재한다. 베타 글루칸은 중성의 용액상태에서는 녹지 않기 때문에 발효액 중의 베타 글루칸을 세포와 분리하기 위해 배양액을 염기화시켜 베타 글루칸을 용해시킨 후 원심분리 또는 필터에 의해 세포를 제거한다. 이 용액을 수용성 유기용매와 접촉시키거나 용액을 중성화시킴으로써 베타 글루칸을 침전시킨 후 원심분리하고 이것을 건조시켜 정제된 분말을 얻는다. 베타 글루칸은 위와 같이 정제되거나 정제되지 않은 형태로도 사용될 수 있다. 본 발명의 실시예에서는 상기 방법으로 정제된 분말형을 사용하였다.Beta glucan was produced by culturing Agrobacterium in a fermentation medium containing sugar as a carbon source, ammonium chloride as a nitrogen source, and other minerals. After fermentation is complete, beta glucan remains in an insoluble state. Since beta glucan is insoluble in a neutral solution state, in order to separate beta glucan from the cells in the fermentation broth, the culture medium is basified to dissolve the beta glucan, and then the cells are removed by centrifugation or a filter. Beta glucan is precipitated by contacting this solution with a water-soluble organic solvent or by neutralizing the solution, followed by centrifugation and drying to obtain a purified powder. Beta glucan can also be used in purified or unpurified form as described above. In the embodiment of the present invention, the powder form purified by the above method was used.
글루타치온은 아미노산 중합체로, 강한 항산화력을 가지며 간기능을 향상시키고 체내 독성 물질의 분해를 돕는 역할을 한다. 또한, 유해한 활성산소를 제거하고 면역체계에 관여하여 T림프구 및 백혈구의 활성을 증가시킴으로써 체내의 면역력를 증진시키고 각종 만성질환 등으로 쇠약해진 동물의 원기를 회복시킬 수 있다. 본 발명의 조성물에서 글루타치온은 베타 글루칸과 함께 작용하여 면역조절능력을 보다 향상시킬 수 있다. Glutathione is an amino acid polymer that has strong antioxidant power, improves liver function, and helps decompose toxic substances in the body. In addition, by removing harmful active oxygen and increasing the activity of T lymphocytes and leukocytes by being involved in the immune system, it is possible to enhance the body's immunity and restore the energy of animals weakened by various chronic diseases. In the composition of the present invention, glutathione can further improve immunomodulatory ability by acting together with beta glucan.
B군 비타민은 비타민 C를 제외한 수용성 비타민으로, 에너지 대사과정에 관여하여 기력을 회복시키고 대사물질의 축적을 저감시킬 수 있다. Group B vitamins are water-soluble vitamins, except for vitamin C, which are involved in the energy metabolism process to restore energy and reduce the accumulation of metabolites.
본 발명에 있어서, 상기 B군 비타민은 비타민 B1, B2 및 B6를 포함하는 것이 바람직하다. 본 발명의 조성물이 B군 비타민으로 비타민 B1, B2 및 B6를 포함하면 동물의 에너지 대사를 향상시키고 동물 성장을 촉진시키는 데 도움을 주어 베타글루칸 및 글루타치온의 대사촉진 및 면역증강 효과를 극대화시킬 수 있다. 또한, 간 및 신장세포에 대한 보호 효과를 나타낼 수 있다.In the present invention, the group B vitamins preferably include vitamins B 1 , B 2 and B 6 . When the composition of the present invention includes vitamins B 1 , B 2 and B 6 as group B vitamins, it helps to improve energy metabolism of animals and promote animal growth, maximizing the effect of promoting metabolism of beta-glucan and glutathione and enhancing immunity. can make it In addition, it can exhibit protective effects on liver and kidney cells.
상기 B군 비타민은 콜린 및 이노시톨을 더 포함하는 것이 보다 바람직하다. 본 발명의 조성물이 B군 비타민으로 콜린 및 이노시톨을 더 포함하면 어류에 대한 안정성을 보다 향상시킬 수 있다.More preferably, the group B vitamins further include choline and inositol. When the composition of the present invention further includes choline and inositol as group B vitamins, stability to fish can be further improved.
이스트(Yeast)는 자연계의 과실표면, 수액, 꽃의 밀샘, 우유등에 널리 분포 되어 있고 특히 아미노산 조성이 우수한 단백질(50 ~ 55%)을 다량 함유하고 있고, 핵산함량 (RNA 8%, DNA 0.3%)도 정어리보다 7배나 많아 효모자체가 아주 우수한 건강 첨가제이며 장내에 유해균을 억제하는 역할을 한다.Yeast is widely distributed in natural fruit surfaces, sap, flower glands, milk, etc., and especially contains a large amount of protein (50 ~ 55%) with excellent amino acid composition, and nucleic acid content (RNA 8%, DNA 0.3%) ) is 7 times more than sardines, so yeast itself is an excellent health additive and plays a role in suppressing harmful bacteria in the intestines.
필요에 따라, 본 발명의 조성물은 타우린, UDCA(Ursodeoxycholic acid) 및 메티오닌으로 이루어진 군에서 선택되는 적어도 하나를 더 포함할 수 있다. 본 발명의 조성물이 타우린, UDCA(Ursodeoxycholic acid) 및 메티오닌으로 이루어진 군에서 선택되는 적어도 하나를 더 포함하는 경우에 대사촉진 및 면역조절 효과를 보다 향상시킬 수 있다.If necessary, the composition of the present invention may further include at least one selected from the group consisting of taurine, UDCA (Ursodeoxycholic acid) and methionine. When the composition of the present invention further contains at least one selected from the group consisting of taurine, UDCA (Ursodeoxycholic acid) and methionine, the effect of promoting metabolism and immunoregulation can be further improved.
본 발명의 조성물에 있어서, 상기 타우린, UDCA(Ursodeoxycholic acid) 및 메티오닌으로 이루어진 군에서 선택되는 적어도 하나는 100중량부로 포함될 수 있다. 상기 함량 범위 내에서 소환기관 및 간에 부담을 주지 않으면서 간기능 향상 및 면역능력 증진 효과를 나타낼 수 있다.In the composition of the present invention, at least one selected from the group consisting of taurine, UDCA (Ursodeoxycholic acid) and methionine may be included in 100 parts by weight. Within the above content range, it is possible to exhibit the effect of improving liver function and enhancing immunity without burdening the summoning organs and liver.
본 발명의 조성물의 투여방법에는 제한이 없다. 예를 들면, 경구 또는 비경구로 투여할 수 있다.The method of administration of the composition of the present invention is not limited. For example, it can be administered orally or parenterally.
본 발명에 따른 어류용 사료 첨가제는 동물용 사료 첨가제로 제조될 수 있다. 본 발명의 동물용 사료 첨가제는 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 포유류, 조류 및 어류에 허용되는 담체 또는 안정제를 더 포함할 수 있다. 상기 담체 또는 안정제로는, 예를 들면 비타민, 아미노산류, 탄수화물, 지방, 미네랄, 항산화제, 항생물질, 항균제 및 기타 첨가제 등을 포함할 수 있으며, 이에 한정되지는 않는다. The feed additive for fish according to the present invention may be prepared as an animal feed additive. The animal feed additive of the present invention may further include a carrier or stabilizer acceptable to mammals, birds, and fish according to a method that can be easily performed by those skilled in the art. The carrier or stabilizer may include, for example, vitamins, amino acids, carbohydrates, fats, minerals, antioxidants, antibiotics, antibacterial agents, and other additives, but is not limited thereto.
본 발명의 동물용 사료 첨가제의 형상은 특별히 한정되지는 않으며, 예를 들면 분체, 과립, 펠릿, 현탁액 등의 형상일 수 있다. 본 발명의 동물용 사료 첨가제는 포유류, 조류 및 어류에 대하여 단독으로 또는 사료에 혼합되어 공급될 수 있다.The shape of the animal feed additive of the present invention is not particularly limited, and may be, for example, powder, granule, pellet, suspension or the like. The animal feed additive of the present invention may be supplied alone or mixed with feed for mammals, birds and fish.
본 발명에 따른 어류용 사료 첨가제는 동물용 의약품 등 약제학적 제제로 제조될 수 있다. 본 발명의 약제학적 제제는 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약제학적으로 허용되는 담체, 희석제 및 부형제로 이루어진 군에서 선택되는 적어도 하나를 이용하여 제제화 함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기 내에 내입시켜 제조될 수 있다. 이때 제형은 동물용 주사제, 산제, 액제, 과립제 또는 정제일 수 있으나 이에 한정되는 것은 아니다. 예를 들면, 동물용 주사제 및 경구용 액제로 제조되는 경우에는 증류수, 에틸올레이트, 에탄올, 프로필렌글리콜, 글리세린 등을 사용하여 제제화될 수 있고 항산화제로 아스코르빈산, 아황산수소나트륨, 피로아황산나트륨, 토코페롤 등을 더 포함할 수 있으나 이에 한정되는 것은 아니다. 동물용 산제 및 과립제로 제조되는 경우에는 비타민류, 글루코스, 락토스, 전분, 효소 등을 사용하여 제형화될 수 있으나 이에 한정되는 것은 아니다.The feed additive for fish according to the present invention can be manufactured into pharmaceutical preparations such as veterinary drugs. The pharmaceutical preparation of the present invention uses at least one selected from the group consisting of pharmaceutically acceptable carriers, diluents and excipients according to a method that can be easily performed by those skilled in the art. By formulating it, it can be prepared in unit dose form or prepared by inserting it into a multi-dose container. At this time, the formulation may be an animal injection, powder, liquid, granule or tablet, but is not limited thereto. For example, in the case of preparation of animal injections and oral solutions, distilled water, ethyl oleate, ethanol, propylene glycol, glycerin, etc. may be used, and as antioxidants, ascorbic acid, sodium hydrogen sulfite, sodium pyrosulfite, It may further include tocopherol and the like, but is not limited thereto. When prepared as animal powders and granules, it may be formulated using vitamins, glucose, lactose, starch, enzymes, etc., but is not limited thereto.
본 발명의 약제학적 제제는 경구 또는 비경구 투여될 수 있다. 상세하게는, 경구 투여일 경우에는 직접 경구 또는 음용수에 혼합하여 투여하거나 사료에 혼합하여 투여할 수 있고, 비경구 투여일 경우에는 통상 근육주사의 방법으로 투여될 수 있으나 이에 한정되는 것은 아니다. 본 발명의 약제학적 제제의 투여량은 투여 대상 동물의 종류, 체중, 연령 등에 따라 조절될 수 있으며, 적합한 투여량은 당업계에서 적합한 지식을 가진 자에 의해 조절될 수 있다.The pharmaceutical preparations of the present invention may be administered orally or parenterally. Specifically, in the case of oral administration, it can be administered directly orally or by mixing with drinking water or by mixing with feed, and in the case of parenteral administration, it can be administered by conventional intramuscular injection, but is not limited thereto. The dosage of the pharmaceutical preparation of the present invention may be adjusted according to the type, weight, age, etc. of the animal to be administered, and an appropriate dosage may be adjusted by those skilled in the art.
이하, 본 발명의 이해를 돕기 위하여 본 발명을 하기 실시예에 의거하여 좀 더 상세하게 설명한다. 단, 이들 실시예는 본 발명을 예시하는 것일 뿐 첨부된 특허청구범위를 제한하는 것이 아니며, 본 발명의 범주 및 기술사상 범위 내에서 실시예에 대한 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다.Hereinafter, in order to aid understanding of the present invention, the present invention will be described in more detail based on the following examples. However, these examples are merely illustrative of the present invention and do not limit the scope of the appended claims, and it is obvious to those skilled in the art that various changes and modifications to the examples are possible within the scope and spirit of the present invention. However, it is natural that such variations and modifications fall within the scope of the appended claims.
실시예Example
<어류용 사료 첨가제의 제조> <Manufacture of feed additives for fish>
하기 표 1의 조성을 담체와 혼합하여 조성물 1kg을 제조하였다.1 kg of the composition was prepared by mixing the composition of Table 1 with a carrier.
<어류에서의 면역 증강 효과 측정> <Measurement of immune enhancing effect in fish>
본 발명에 따른 면역 증강용 조성물의 효과를 확인하기 위하여, 상기 표 1의 실시예 1, 실시예 2 및 비교예 1을 넙치, 우럭(조피볼락), 농어 및 뱀장어 사료에 각각 1톤당 1kg 함량으로 혼합하여 4주 동안 급여하였다. 별도의 사료 첨가제 없이 사료만을 급여한 어류를 대조군으로 이용하였다. 실험에 사용한 어류는 미부혈관을 통해 혈액을 채취하고 헤파린 처리된 튜브에 담아 면역활성과 관련된 지표를 측정하여 면역 증강 효과를 확인하였다. 어류에서 비특이적 면역능의 척도로 이용되는 혈액 중 lysozme의 활성, 일반적인 어류의 면역지표로 활용되는 혈액 내 lymphocyte와 neutrophil의 수, 식세포의 활성을 측정하기 위한 nitroblue tetrazolium (NBT) 활성 및 활성산소 제거능력을 측정하기 위한 superoxide dismutase(SOD) 활성을 측정하고 그 결과를 하기 표 2에 나타냈다. 하기 표 2에서 NBT activity는 540nm에서 측정하였으며, 각각의 대조군과 비교하여 통계적으로 특히 유의한 차이를 보이는 값(*P<0.05)은 별도표기하였다. In order to confirm the effect of the immune enhancing composition according to the present invention, Example 1, Example 2 and Comparative Example 1 in Table 1 were mixed with halibut, rockfish (rockfish), sea bass and eel feed at an amount of 1 kg per 1 ton, respectively. and paid for 4 weeks. Fish fed only feed without additional feed additives were used as a control group. The fish used in the experiment were collected with blood through the caudal vein and put in a heparinized tube to measure indicators related to immune activity to confirm the immune enhancing effect. The activity of lysozme in the blood used as a measure of non-specific immune ability in fish, the number of lymphocytes and neutrophils in the blood used as an immune indicator in general fish, nitroblue tetrazolium (NBT) activity to measure the activity of phagocytes, and the ability to remove active oxygen To measure superoxide dismutase (SOD) activity was measured and the results are shown in Table 2 below. In Table 2 below, NBT activity was measured at 540 nm, and values showing statistically particularly significant differences (*P<0.05) compared to each control group were marked separately.
fish species
division
(Units/ml)Lysozyme
(Units/ml)
(%)Neutrophil
(%)
activityNBT
activity
activity
(Units/ml)SOD
activity
(Units/ml)
halibut
Rockfish
bass
eel
상기 표 2를 참고하면, 본 발명의 조성물인 실시예 1 또는 실시예 2를 포함하는 사료를 급여한 경우 대조군 및 비교예 1의 사료를 급여한 경우에 비해 면역지표 값이 증가한 것을 확인할 수 있다. 이를 통하여, 본 발명의 조성물이 어류에서 우수한 면역력 증가 효과를 보이는 것을 확인할 수 있다.Referring to Table 2, it can be seen that when feeding the feed containing the composition of the present invention Example 1 or Example 2, the immune index value increased compared to the case of feeding the feed of the control group and Comparative Example 1. Through this, it can be confirmed that the composition of the present invention shows an excellent immunity increasing effect in fish.
<어류에서의 간에 대한 효과 측정> <Measurement of liver effects in fish>
본 발명에 따른 면역 증강용 조성물의 간에 대한 독성을 확인하기 위하여, 상기 표 1의 실시예 2 및 비교예 2를 넙치, 우럭(조피볼락), 농어 및 뱀장어 사료에 각각 1톤당 10kg 함량으로 혼합하여 4주 동안 급여하였다. 별도의 사료 첨가제 없이 사료만을 급여한 어류를 대조군으로 이용하였다. 실험에 사용한 어류는 미부혈관을 통해 혈액을 채취하고 헤파린 처리된 튜브에 담아 간 활성과 관련된 효소인 효소인 aspartate aminotransferase (AST)와 alanine aminotransferase (ALT) 농도를 측정하고 그 결과를 하기 표 3에 나타냈다. 각각의 실시예 2 실험군의 경우 비교예 2 실험군과 비교하여 통계적으로 특히 유의한 차이를 보이는 값(*P<0.05)은 별도표기하였다. In order to confirm the toxicity of the immune enhancing composition according to the present invention to the liver, Example 2 and Comparative Example 2 in Table 1 were mixed with halibut, rockfish (rockfish), perch and eel feed at an amount of 10 kg per ton, respectively. paid for a week. Fish fed only feed without additional feed additives were used as a control group. For the fish used in the experiment, blood was collected through the caudal vessel and placed in a heparinized tube to measure the concentrations of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which are enzymes related to liver activity, and the results are shown in Table 3 below. . In the case of each Example 2 experimental group, a value showing a statistically significant difference (*P<0.05) compared to the Comparative Example 2 experimental group was marked separately.
fish species
division
Rockfish
eel
상기 표 3을 참고하면, 본 발명의 조성물인 실시예 2를 포함하는 사료를 급여한 경우 대조군 및 비교예 1의 사료를 급여한 경우에 비해 간 활성효소 수치값이 증가한 것을 확인할 수 있다. 이를 통하여, 본 발명의 조성물이 어류에서 간의 활성효과를 증진시키는 것을 확인할 수 있다.Referring to Table 3, it can be seen that when feeding the feed containing the composition of Example 2 of the present invention, the liver active enzyme value increased compared to the case of feeding the feed of the control group and Comparative Example 1. Through this, it can be confirmed that the composition of the present invention enhances the liver activity in fish.
Claims (3)
베타글루칸 77 내지 84 중량부;
B군 비타민 5 내지 6 중량부;
이스트 0.01 내지 1 중량부; 및
타우린, UDCA 및 메티오닌으로 이루어진 군에서 선택되는 적어도 하나를 100 중량부로 포함하는 것을 특징으로 하는 어류용 사료 첨가제.
34 to 38 parts by weight of glutathione;
77 to 84 parts by weight of beta glucan;
5 to 6 parts by weight of group B vitamins;
0.01 to 1 part by weight of yeast; and
A feed additive for fish, comprising 100 parts by weight of at least one selected from the group consisting of taurine, UDCA and methionine.
상기 B군 비타민은 비타민 B1, 비타민 B2, 비타민 B6, 콜린 및 이노시톨을 포함하는 것을 특징으로 하는 어류용 사료 첨가제.
According to claim 1,
The B group vitamins include vitamin B 1 , vitamin B 2 , vitamin B 6 , choline and inositol.
36.5 parts by weight of glutathione, 80 parts by weight of beta glucan, 100 parts by weight of taurine, 1.5 parts by weight of vitamin B 1 , 3.75 parts by weight of vitamin B 2 , 0.9 parts by weight of vitamin B 6 , and 0.01 to 1 part by weight of yeast.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210082807A KR20230000565A (en) | 2021-06-25 | 2021-06-25 | A Feed Stuff Additives for farming fish |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210082807A KR20230000565A (en) | 2021-06-25 | 2021-06-25 | A Feed Stuff Additives for farming fish |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230000565A true KR20230000565A (en) | 2023-01-03 |
Family
ID=84924763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210082807A KR20230000565A (en) | 2021-06-25 | 2021-06-25 | A Feed Stuff Additives for farming fish |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230000565A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070031815A (en) | 2005-09-15 | 2007-03-20 | 백우현 | Feed additive and livestock bred by the feed additive |
-
2021
- 2021-06-25 KR KR1020210082807A patent/KR20230000565A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070031815A (en) | 2005-09-15 | 2007-03-20 | 백우현 | Feed additive and livestock bred by the feed additive |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Terova et al. | Effects of sodium butyrate treatment on histone modifications and the expression of genes related to epigenetic regulatory mechanisms and immune response in European sea bass (Dicentrarchus labrax) fed a plant-based diet | |
Ming et al. | Effects of emodin and vitamin C on growth performance, biochemical parameters and two HSP70s mRNA expression of Wuchang bream (Megalobrama amblycephala Yih) under high temperature stress | |
EP1413303B1 (en) | Swine growth promoters and method of promoting swine growth | |
CN109512999A (en) | The application of synergetic effect additive of the fatty alcohol of oxygen-containing hydrocarbon derivative as polymyxins | |
EP0910363B1 (en) | Veterinary use of a pleuromutilin derivative | |
KR20230000565A (en) | A Feed Stuff Additives for farming fish | |
KR20170135775A (en) | A Feed Stuff Additives for farming fish | |
Khan et al. | Enhancing bovine immune, antioxidant and anti-inflammatory responses with vitamins, rumen-protected amino acids, and trace minerals to prevent periparturient mastitis | |
EP0091762B1 (en) | Process for the production of an iron-selenium trace element solution | |
Karasawa et al. | Inhibitory effect of penicillin on caecal urease activity in chickens fed on a low protein diet plus urea | |
KR20160070044A (en) | A Feed Stuff Additives for farming fish | |
CN112891363B (en) | New Zealand vitexin 2 and new Zealand vitexin 3 application | |
CN111568912B (en) | Glycyrrhizic acid and probiotics are combined to be used as feed additive for relieving vomitoxin harm | |
KR20160088486A (en) | Pharmaceutical composition for animal | |
Xu et al. | Effects of dietary vitamin E on the growth performance, immunity and digestion of Epinephelus fuscoguttatus♀× Epinephelus lanceolatus♂ by physiology, pathology and RNA-seq | |
CN111642626A (en) | Feed additive for promoting growth of aquatic animals and application thereof | |
CN110960541B (en) | Pharmaceutical composition for penaeus vannamei | |
KR101164927B1 (en) | Feed additive including quercetin from onion as a antibiotic alternative, feed composition and its feeding method | |
CH646059A5 (en) | ANTIBIOTIC COMPOSITIONS CONTAINING A MACROLIDE AND AN AMINOHETEROSIDE. | |
RU2344824C2 (en) | Medicine for treatment of fish infection diseases of bacterial etiology and treatment method fish infection diseases of bacterial etiology | |
CN106889317B (en) | Early weaning promoter for young ruminants and feeding method thereof | |
Mukharlyamova et al. | Application of retinyl acetate in rabbit aflatoxicosis | |
EP3354268A1 (en) | Tumor prevention and treatment drug and applications thereof | |
Smychok et al. | System of antioxidant protection of young cattle under cadmium load | |
RU2816721C1 (en) | Method for prevention of hepatosis in laying hens |